Skip to content

Comparison of sedation effects of sufentanil and midazolam with nitrous oxide in cataract surgery

Comparation of sedation sufentanil and midazolam with nitrous oxide in patients of cataract surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015011314333N28
Enrollment
100
Registered
2015-01-31
Start date
2014-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cataract surgery. Disorder of vitreous body, unspecified

Interventions

Intervention 1: The experiment group received a mixture of nitrous oxide (aspiration gas with oxygen made in Iran Darman Gaz) and oxygen company with ratio of %66 and %33 in Face mask with flow of 6 l
Treatment - Drugs
The experiment group received a mixture of nitrous oxide (aspiration gas with oxygen made in Iran Darman Gaz) and oxygen company with ratio of %66 and %33 in Face mask with flow of 6 lit/min while it
The experiment group received 5 Milligram of sufentanil (common treatment) (the injection of mic/ml made of Teharan Daroopakhsh company-Iran) and 1 milligram of IV midazolam 5 mg/ml (produced by Teh

Sponsors

Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion: satisfaction of patients; candidates to cataract surgery; Exclusion: people under 18 or over 80; pregnant women; patients with chronic lung diseases; heart failure with chronic hypoxemia; addicts; patients who experienced general anesthesia or surgeries longer than 30 minutes.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood pressure. Timepoint: Every 5 minutes before the surgery, beginning the surgery and during the surgery; after the surgery and before transferring the patient to recovery room. Method of measurement: Recording blood pressure with monitoring tools.;Heart beat. Timepoint: Every 5 minutes before the surgery, beginning the surgery and during the surgery; after the surgery and before transferring the patient to recovery room. Method of measurement: The number of heart beats recorded by monitoring tool.;Vain blood oxygen saturation. Timepoint: Every 5 minutes before the surgery, beginning the surgery and during the surgery; after the surgery and before transferring the patient to recovery room. Method of measurement: Based on ratio of vein blood oxygen saturation recorded by monitoring and pulse oximetry tools.;Patient movement. Timepoint: Beginning the surgery and every 5 minutes to the end of the surgery. Method of measurement: By the doctor.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026